Singular Genomics Systems Inc
NASDAQ:OMIC
Singular Genomics Systems Inc
Selling, General & Administrative
Singular Genomics Systems Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
Selling, General & Administrative
-$52.6m
|
CAGR 3-Years
-103%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Selling, General & Administrative
-$8.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Danaher Corp
NYSE:DHR
|
Selling, General & Administrative
-$13.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Selling, General & Administrative
-$903.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
Agilent Technologies Inc
NYSE:A
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
See Also
What is Singular Genomics Systems Inc's Selling, General & Administrative?
Selling, General & Administrative
-52.6m
USD
Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Selling, General & Administrative amounts to -52.6m USD.
What is Singular Genomics Systems Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-103%
Over the last year, the Selling, General & Administrative growth was -11%. The average annual Selling, General & Administrative growth rates for Singular Genomics Systems Inc have been -103% over the past three years .